Immediate Impact

1 by Nobel laureates 2 from Science/Nature 51 standout
Sub-graph 1 of 23

Citing Papers

Breastfeeding: crucially important, but increasingly challenged in a market-driven world
2023 Standout
Targeting the tumor stroma for cancer therapy
2022 Standout
1 intermediate paper

Works of Henrik Roed being referenced

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial
2019
[Infants with colic. A heterogenous group possible to cure? Treatment by pediatric consultation followed by a study of the effect of zone therapy on incurable colic].
2001

Author Peers

Author Last Decade Papers Cites
Henrik Roed 738 328 305 508 456 53 1.7k
Fernanda Herrera 603 118 208 557 239 62 1.5k
Imran Zoberi 291 216 133 500 662 89 2.0k
Wei Deng 384 79 325 395 184 87 1.4k
Paolo Passoni 1356 76 114 791 209 93 1.9k
Hywel Madoc‐Jones 275 155 259 210 191 42 1.4k
Yuji Seo 466 43 314 529 352 107 1.4k
James Jer‐Min Jian 760 30 171 465 299 32 1.9k
Katja Lindel 701 73 314 459 117 60 1.8k
H Lambert 470 926 202 231 91 49 1.7k
Skye Hongiun Cheng 548 32 261 412 182 32 1.6k

All Works

Loading papers...

Rankless by CCL
2026